Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
BHC · against 334 other Healthcare companies of similar size
Ranked #166 of 335 · scores higher than 50% of peers
Bars: peers in each 10-point band of the valuation score31 peers with a valuation score of 50–59, including BHC · Click a bar to see the companies
A mix: stronger free cash flow yield and EBITDA yield, but weaker earnings yield than most Healthcare peers.
| Metric | BHC | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 329 reported | -27.8% | 2.3% | 3% | 30% | |
| EBITDA yieldHigher is better · 330 reported | 18.7% | 4.7% | 97% | 50% | |
| Free cash flow yieldHigher is better · 176 reported | 60.0% | 0.1% | 100% | 20% | |
| Book yieldHigher is better · 327 reported | -43.6% | 29.6% | 0% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 12.9B HKD (≈$1.7B) | 99 | 83 | |
| 1 | 226.3B JPY (≈$1.5B) | 99 | 77 | |
| 1 | 37.3B HKD (≈$4.8B) | 99 | 90 | |
| 161 | 2.8B USD | 57 | 33 | |
| 161 | 1.8B USD | 57 | 52 | |
| 161 | 2.9B USD | 57 | 50 | |
| 161 | 41.9B SEK (≈$4.2B) | 57 | 53 | |
| 166 | 3.0B USD | 56 | 35 | |
| 166 | 2.2B CAD (≈$1.6B) | 56 | 44 | |
| 168 | 414.8B INR (≈$5.0B) | 55 | 73 | |
| 168 | 494.7B INR (≈$5.9B) | 55 | 70 | |
| 168 | 1.6B USD | 55 | 51 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score